Core Viewpoint - The article emphasizes the hope and determination of ALS patients, particularly highlighting the efforts of Cai Lei, who, despite being in the terminal stage of the disease, believes in the potential breakthroughs in research and treatment by 2026 [1][2][3]. Group 1: Patient Experience and Challenges - Cai Lei, who has been battling ALS for six years, describes his severe physical limitations and the emotional toll of the disease, stating that he feels trapped in his own body while his mind remains clear [2][3]. - The article details the lack of effective treatments for ALS, with no current drugs available to halt or reverse the disease, leading to a sense of despair among patients [2][3]. Group 2: Research and Collaboration Efforts - Cai Lei's team has engaged with over 60 top research teams and more than 50 biotech companies, resulting in nearly 100 collaborative research projects and 15 drug pipeline breakthroughs [3][4]. - The establishment of the "Gradual Recovery Mutual Aid Home" has led to a significant increase in registered ALS patients, surpassing 18,000, creating a substantial patient cohort for research [3][4]. Group 3: Technological Advancements - The rapid development of artificial intelligence has significantly enhanced research capabilities, allowing the team to analyze nearly 40,000 ALS research papers and rank hundreds of drugs based on preclinical trial results [4][5]. - Cai Lei's team aims to leverage cutting-edge technologies, including brain-machine interfaces and embodied intelligence, to develop nursing robots that can assist ALS patients, thereby alleviating the burden on families [6]. Group 4: Community and Support - Cai Lei highlights the importance of community support, stating that family, friends, and fellow patients have provided him with warmth and confidence during his journey [6]. - The article illustrates the solidarity among ALS patients, with Cai Lei maintaining communication with over 40 patient groups, offering encouragement despite his own challenges [5][6].

Core Viewpoint - The letter from Cai Lei emphasizes hope and determination in the fight against amyotrophic lateral sclerosis (ALS), highlighting the advancements in technology and research that could lead to breakthroughs in treatment by 2026 [1][2]. Group 1: Research and Development - Cai Lei's team has collaborated with over 60 top research teams and more than 50 biotech companies, resulting in nearly 100 ALS research projects and 15 drug pipeline breakthroughs for clinical translation [2]. - The establishment of the "ALS Mutual Aid Home" has registered over 18,000 patients, creating a significant ALS patient cohort for research [2]. - The development of an AI research platform has analyzed nearly 40,000 ALS research papers and ranked hundreds of drugs based on preclinical trial results, significantly increasing research efficiency [3]. Group 2: Patient Support and Community - Cai Lei maintains over 40 support groups for ALS patients, fostering a sense of community and mutual encouragement among patients despite their physical challenges [4]. - The team has successfully established and promoted a care system for ALS patients, reducing the high costs of care equipment through social support [3]. Group 3: Future Aspirations - The team aims to accelerate drug development and collaborate with cutting-edge technologies like brain-machine interfaces and embodied intelligence to create caregiving robots that alleviate the physical and financial burdens on ALS patients' families [5]. - Cai Lei believes that breakthroughs in ALS treatment could lead to significant advancements in addressing other medical challenges, such as Alzheimer's disease [5].